Month: <span>October 2018</span>

Home / 2018 / October
Post

Age, sex, APOE genotype identify alzheimer’s, dementia risk

(HealthDay)—Age, sex and apolipoprotein E (APOE) genotype can identify groups at high 10-year risk for Alzheimer’s disease and all dementia, according to a study published Sept. 4 in CMAJ, the journal of the Canadian Medical Association. Katrine L. Rasmussen, M.D., Ph.D., from Copenhagen University Hospital in Denmark, and colleagues used data from the Copenhagen General Population...

Post

Giving millions of patients already on statins a new type of drug ‘could slash their heart disease risk even further’ and protect against type 2 diabetes

Pills called lipoprotein lipase (LPL) enhancers are already under development Cambridge University scientists claim they can slash the risk of heart disease They tested the effects of the drugs based on genes from 400,000 people Giving millions of patients already taking statins a new type of drug could slash their heart disease risk even further, research suggests....

Post

Weight loss can be boosted fivefold thanks to novel mental imagery technique

A new study has shown how overweight people lost an average of five times more weight using Functional Imagery Training (FIT) UNIVERSITY OF PLYMOUTH Overweight people who used a new motivational intervention called Functional Imagery Training (FIT) lost an average of five times more weight than those using talking therapy alone, shows new research published...

Post

Six simple, positive ways to engage with someone with autism

“You’ve met one person with autism, then you’ve met one person with autism.” This saying is an important reminder among all who live and work with people with autism that each person living with the condition is indeed distinct, said Lonnie Zwaigenbaum, professor and director of the autism research centre in the Division of Developmental Pediatrics at the...

Post

A new remedy for celiac disease

In an industrial collaboration project, TU Wien has developed a medication that can alleviate or even completely eliminate the symptoms of celiac disease. It should be available as early as 2021. Only the part of the antibody (left) that binds to gluten is needed to create a product, which does not trigger an immune response....

Post

EverSleep Wearable Sleep Tracker: Product Review and Interview with CEO

Readers might recall the 2017 Indiegogo campaign by SomnoHealth to create EverSleep, a wearable sleep tracker with built-in oxygenation monitoring. The campaign reached 224% of its original goal in addition to receiving a $50k Arrow Electronics Flash Funding Grant and recognition as a 2017 National Sleep Foundation SleepTech 2017 Semifinalist. Today, the EverSleep device is...

Post

Amarin fish oil capsule shows dramatic benefit for cardiovascular patients, potentially upending market

The biopharma company Amarin is making some heart-medicine history Monday with its proprietary, prescription formulation of fish oil, called Vascepa. In a stunning clinical trial result that upends years of skepticism about the long-term heart benefit of products containing omega-3 fatty acids, Amarin’s Vascepa significantly reduced the risk of deaths, heart attacks, strokes, and other...

Post

New way of determining treatment for staph infections cuts antibiotic use

Using a clinical checklist to identify eligible patients, doctors were able to shorten the antibiotic duration for patients with uncomplicated staphylococcal bloodstream infections by nearly two days, Duke Health researchers report. Credit: CC0 Public Domain That’s good news for individual patients and could also help reduce antibiotic resistance on a broader scale. “Staphylococci are among...